Drug
Ensifentrine Dose 1
Ensifentrine Dose 1: highest development phase Phase 2, developed by Verona Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Verona Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Ensifentrine Dose 1 NCT04527471 | Phase 2 | Coronavirus Infection |
Latest
No recent events.
Follow Ensifentrine Dose 1 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.